Major medical organizations updated the cholesterol playbook for the first time in years, with new risk tools, lower targets ...
Lipid-lowering therapy can be considered with a 10-year PREVENT-ASCVD risk estimate of 3% to <5% (borderline) and should be considered for those at 5% to <10% (intermediate) 10-year risk. For ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results